Literature DB >> 31874251

Increased formation of reactive oxygen species during tumor growth: Ex vivo low-temperature EPR and in vivo bioluminescence analyses.

Gang Cheng1, Jing Pan2, Radoslaw Podsiadly3, Jacek Zielonka4, Alexander M Garces5, Luiz Gabriel Dias Duarte Machado5, Brian Bennett5, Donna McAllister6, Michael B Dwinell7, Ming You8, Balaraman Kalyanaraman9.   

Abstract

Previous studies have shown that reactive oxygen species (ROS) such as superoxide or hydrogen peroxide generated at low levels can exert a tumor-promoting role via a redox-signaling mechanism. Reports also suggest that both tumorigenesis and tumor growth are associated with enhanced ROS formation. However, whether ROS levels or ROS-derived oxidative marker levels increase during tumor growth remains unknown. In this study, in vivo bioluminescence imaging with a boronate-based pro-luciferin probe was used to assess ROS formation. Additionally, probe-free cryogenic electron paramagnetic resonance was used to quantify a characteristic aconitase [3Fe4S]+ center that arises in the tumor tissue of mouse xenografts from the reaction of the native [4Fe4S]2+ cluster with superoxide. Results indicated that tumor growth is accompanied by increased ROS formation, and revealed differences in oxidant formation in the inner and outer sections of tumor tissue, respectively, demonstrating redox heterogeneity. Studies using luciferin and pro-luciferin probes enabled the assessment of tumor size, ROS formation, and bioenergetic status (e.g., ATP) in luciferase-transfected mice tumor xenografts. Probe-free ex vivo low-temperature electron paramagnetic resonance can also be translated to clinical studies.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bioluminescence; EPR; Mitochondria; Oxidants; Tumor growth

Mesh:

Substances:

Year:  2019        PMID: 31874251      PMCID: PMC6948008          DOI: 10.1016/j.freeradbiomed.2019.12.020

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  65 in total

1.  An EPR investigation of the products of the reaction of cytosolic and mitochondrial aconitases with nitric oxide.

Authors:  M C Kennedy; W E Antholine; H Beinert
Journal:  J Biol Chem       Date:  1997-08-15       Impact factor: 5.157

Review 2.  Targeting reactive oxygen species in development and progression of pancreatic cancer.

Authors:  Nisha Durand; Peter Storz
Journal:  Expert Rev Anticancer Ther       Date:  2016-11-23       Impact factor: 4.512

3.  Detection of mitochondria-generated reactive oxygen species in cells using multiple probes and methods: Potentials, pitfalls, and the future.

Authors:  Gang Cheng; Monika Zielonka; Brian Dranka; Suresh N Kumar; Charles R Myers; Brian Bennett; Alexander M Garces; Luiz Gabriel Dias Duarte Machado; David Thiebaut; Olivier Ouari; Micael Hardy; Jacek Zielonka; Balaraman Kalyanaraman
Journal:  J Biol Chem       Date:  2018-05-08       Impact factor: 5.157

Review 4.  Modulation of oxidative stress as an anticancer strategy.

Authors:  Chiara Gorrini; Isaac S Harris; Tak W Mak
Journal:  Nat Rev Drug Discov       Date:  2013-12       Impact factor: 84.694

Review 5.  Cancer cell killing via ROS: to increase or decrease, that is the question.

Authors:  Jie Wang; Jing Yi
Journal:  Cancer Biol Ther       Date:  2008-12-24       Impact factor: 4.742

6.  The cellular production of hydrogen peroxide.

Authors:  A Boveris; N Oshino; B Chance
Journal:  Biochem J       Date:  1972-07       Impact factor: 3.857

7.  Reversal of Warburg Effect and Reactivation of Oxidative Phosphorylation by Differential Inhibition of EGFR Signaling Pathways in Non-Small Cell Lung Cancer.

Authors:  Viviana De Rosa; Francesca Iommelli; Marcello Monti; Rosa Fonti; Giuseppina Votta; Maria Patrizia Stoppelli; Silvana Del Vecchio
Journal:  Clin Cancer Res       Date:  2015-07-27       Impact factor: 12.531

8.  Real time monitoring and quantification of reactive oxygen species in breast cancer cell line MCF-7 by 2',7'-dichlorofluorescin diacetate (DCFDA) assay.

Authors:  Daniela Figueroa; Mohammad Asaduzzaman; Fiona Young
Journal:  J Pharmacol Toxicol Methods       Date:  2018-04-07       Impact factor: 1.950

9.  Heterogeneity in the clinical phenotype of TP53 mutations in breast cancer patients.

Authors:  J Alsner; M Yilmaz; P Guldberg; L L Hansen; J Overgaard
Journal:  Clin Cancer Res       Date:  2000-10       Impact factor: 12.531

10.  Oxidative stress inhibits distant metastasis by human melanoma cells.

Authors:  Elena Piskounova; Michalis Agathocleous; Malea M Murphy; Zeping Hu; Sara E Huddlestun; Zhiyu Zhao; A Marilyn Leitch; Timothy M Johnson; Ralph J DeBerardinis; Sean J Morrison
Journal:  Nature       Date:  2015-10-14       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.